Nationwide Fund Advisors’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-80,302	Closed	-$8.67M	–	475
2017 Q3	$8.67M	Sell	80,302 -699	-0.9%	-$71.8K	0.03%	735
2017 Q2	$8.19M	Buy	81,001 +2,160	+3%	+$199K	0.03%	747
2017 Q1	$7.09M	Buy	78,841 +161	+0.2%	+$13.7K	0.03%	822
2016 Q4	$6M	Sell	78,680 -18,977	-19%	-$1.44M	0.02%	899
2016 Q3	$8.14M	Buy	97,657 +11,864	+14%	+$995K	0.03%	722
2016 Q2	$7.07M	Buy	85,793 +8,535	+11%	+$703K	0.03%	767
2016 Q1	$5.87M	Buy	77,258 +2,615	+4%	+$194K	0.03%	845
2015 Q4	$6M	Sell	74,643 -45	-0.1%	-$3.25K	0.03%	831
2015 Q3	$4.74M	Sell	74,688 -1,029	-1%	-$73.9K	0.02%	940
2015 Q2	$5.33M	Sell	75,717 -1,881	-2%	-$139K	0.02%	931
2015 Q1	$6.15M	Buy	77,598 +951	+1%	+$70.2K	0.02%	877
2014 Q4	$4.88M	Sell	76,647 -327	-0.4%	-$20.5K	0.02%	957
2014 Q3	$4.6M	Sell	76,974 -2,253	-3%	-$129K	0.02%	992
2014 Q2	$4.24M	Sell	79,227 -138	-0.2%	-$7.57K	0.02%	1081
2014 Q1	$4.79M	Sell	79,365 -2,005	-2%	-$117K	0.02%	888
2013 Q4	$4.32M	Sell	81,370 -2,536	-3%	-$127K	0.02%	1036
2013 Q3	$3.88M	Buy	83,906 +2,022	+2%	+$92.8K	0.02%	1051
2013 Q2	$3.36M	Buy	+81,884	New	+$3.51M	0.02%	1027